Schedule 13G ownership disclosure

NLS PHARMACEUTICS LTD

Security class unavailable · CUSIP: H57830103

Event date: 2024-10-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-087664
Form type
SC 13G
Filer
ALPHA CAPITAL ANSTALT
CIK
CIK 1140358
Filed
Oct 15, 2024
Reporting period
Oct 10, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub